NYSE:MCKHealthcare
Is McKesson (MCK) Undervalued On Softer Results And New Partnerships?
McKesson (MCK) stock has been in focus after a recent 2.09% decline, as investors weighed softer quarterly results against index additions, expanded partnerships and the company’s continued tilt toward higher margin healthcare segments.
See our latest analysis for McKesson.
Over the past year, McKesson’s share price return has been mixed. A recent 4.52% one-month gain contrasts with a 13.14% decline over three months and a 6.73% fall year to date. Total shareholder return over 1, 3 and 5...